Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Recall of selected 300mg tablets
GlaxoSmithKline Inc and Biovail Corp have initiated a recall of selected bottles of 300mg WELLBUTRIN XL tablets. These tablets may contain foreign material embedded in the tablets. The recall applies to: WELLBUTRIN XL 300mg tablets Lot: P08A011, Exp May-09
Learn More

Recall of patches in the United States and Europe
UCB announced today that it will be recalling NEUPRO in the United States and certain batches in Europe. NEUPRO is used for the treatment of Parkinson's disease and is distributed by Schwarz Pharma, a company of UCB Group. UCB has announced this recall because of reduced effectiveness of some of the patches, and NOT because of contamination or safety issues. As a result of this recall, however, NEUPRO will be out-of-stock in the United States from late April 2008. In the European Union and most other regions NEUPRO supply should still be sufficient.
Learn More

Date Published Title Drug Source
2008-03-27 Recall of selected 300mg tablets Bupropion FDA
2008-03-20 Recall of patches in the United States and Europe Rotigotine Manufacturer
2008-03-18 Potential increased risk of stroke identified Tiotropium FDA
2008-03-11 Public health advisory on the proper use of Tussionex Tussionex Pennkinetic FDA
2008-03-11 Public health advisory on the proper use of Tussionex FDA
2008-02-27 Risk of Clinically Significant Liver Injury Natalizumab FDA
2008-02-13 Recall of fentanyl patches Fentanyl Manufacturer
2008-02-08 Early communication regarding FDA safety review Onabotulinumtoxina FDA
2008-02-08 Early communication regarding FDA safety review Rimabotulinumtoxinb FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Carbamazepine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Felbamate FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Gabapentin FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Lamotrigine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Levetiracetam FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Oxcarbazepine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Pregabalin FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Tiagabine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Topiramate FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Divalproex Sodium FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Zonisamide FDA
Back to Consumer Med Safety